Multinational Cohort Validation
Cross-source consensus on Multinational Cohort Validation from 1 sources and 5 claims.
1 sources · 5 claims
Uses
How it works
Evidence quality
Highlighted claims
- The validation study enrolled 6.4 million individuals. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- The study involved 56 co-investigators from academic institutions, research centres, and health systems across 11 countries. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- The study involved 56 co-investigators from academic institutions, research centers, and health systems across 11 countries. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- Geographic diversity in the study was central to assessing how well risk prediction tools generalize across populations. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- Geographic diversity across countries was central to the validation approach, enabling assessment of tool performance across different populations and healthcare contexts. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- Harmonizing data across multiple cohort studies with different data collection methods and measurement protocols was a methodologically complex requirement. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- The data harmonization effort was considered evidence of the study's methodological rigor in testing real-world applicability. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems